The government’s top vaccine official working under Health Secretary Robert F. Kennedy Jr. recently restricted the approval ...

Currently, there are two Moderna COVID-19 vaccines available: SPIKEVAX and the 2024 – 2025 formula. Both vaccines contain similar ingredients. For example, the SPIKEVAX contains the following: ...

Moderna's new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major ...

Findings showed mNexspike showed a 9.3% (99.4% CI, -6.6, 22.8) higher relative vaccine efficacy compared with Moderna’s original COVID-19 vaccine.

People 18 and older who got their primary COVID-19 vaccine shots or their most recent booster shots at least two months ago are eligible to receive a single dose of the new Moderna booster ...

The U.S. government considers you fully vaccinated if you’ve received two primary vaccine doses and one of the updated booster shots, such as the 2024–2025 COVID-19 vaccine.

The Food and Drug Administration (FDA) expanded the approval of Moderna’s RSV vaccine late Thursday to include people 18 to 59 years old who are at increased risk for severe illness from ...

Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial.   In a Phase 3 study, the ...

Moderna is preparing to test Health Secretary Robert F. Kennedy Jr.'s tougher vaccine policies with a combination flu-COVID ...

The Centers for Disease Control and Prevention (CDC) has adopted new vaccine recommendations that expand protection for respiratory syncytial virus (RSV) and meningococcal disease, backing products ...